{"id":67578,"date":"2012-12-22T19:58:47","date_gmt":"2012-12-22T19:58:47","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/oncomed-pharmaceuticals-initiates-phase-1-clinical-trial-of-anti-cancer-stem-cell-therapeutic-omp-52m51-anti-notch1.php"},"modified":"2012-12-22T19:58:47","modified_gmt":"2012-12-22T19:58:47","slug":"oncomed-pharmaceuticals-initiates-phase-1-clinical-trial-of-anti-cancer-stem-cell-therapeutic-omp-52m51-anti-notch1","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/oncomed-pharmaceuticals-initiates-phase-1-clinical-trial-of-anti-cancer-stem-cell-therapeutic-omp-52m51-anti-notch1.php","title":{"rendered":"OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1)"},"content":{"rendered":"<p>REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals advances another anti-cancer stem cell therapy into the clinic and receives a milestone payment from GlaxoSmithKline<\/p>\n<p>See the original post here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.euvolution.com\/r\/_ylt=A2KJjbzuENZQaGkAj73_wgt.\/SIG=144rni9tn\/EXP=1356235118\/**http:\/\/www.businesswire.com\/news\/home\/20121221005091\/en\/OncoMed-Pharmaceuticals-Initiates-Phase-1-Clinical-Trial\" title=\"OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1)\">OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals advances another anti-cancer stem cell therapy into the clinic and receives a milestone payment from GlaxoSmithKline <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/oncomed-pharmaceuticals-initiates-phase-1-clinical-trial-of-anti-cancer-stem-cell-therapeutic-omp-52m51-anti-notch1.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-67578","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/67578"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=67578"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/67578\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=67578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=67578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=67578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}